Waiting Tai

Dr Waiting Tai is a Researcher at the Sydney Pharmacy School, part of the Faculty of Medicine and Health at the University of Sydney. His work focuses on advanced drug delivery systems, particularly inhalation therapies and pharmaceutical formulation innovations. Key areas include aerosol drug design, nanoparticle engineering for bioavailability improvement, and targeted therapies for neurological and infectious diseases. His research integrates analytical techniques like O-PTIR spectroscopy for particle characterization and explores novel approaches such as bacteriophage endolysin powders for pulmonary infections. Recent studies emphasize CBD delivery mechanisms, anti-biofilm agents in antibiotic formulations, and aerosolized treatments for conditions like tuberculosis and COVID-19. Dr Tai’s publications highlight interdisciplinary collaboration between pharmaceutical science and biomedical engineering, aiming to bridge gaps between formulation science and clinical application.

His research interests span pharmaceutical aerosol technology, nanomedicine for CNS delivery, and the development of stable inhalable powders. Notable projects include high-loading CBD powders, spray-freeze-dried formulations with DPPC, and in vitro/in vivo correlations for aerosol performance. While no scientific awards are explicitly listed, his contributions reflect significant innovation in respiratory drug delivery systems.